What is Galectin Therapeutics Inc.'s Market Cap?

Galectin Therapeutics Inc.'s Market Cap is $414.5M, based on as-reported figures from SEC (XBRL) filings.

What is Galectin Therapeutics Inc.'s Enterprise Value?

Galectin Therapeutics Inc.'s Enterprise Value is $403.0M, based on as-reported figures from SEC (XBRL) filings.

What is Galectin Therapeutics Inc.'s Net Income (TTM)?

Galectin Therapeutics Inc.'s Net Income (TTM) is -$28.0M, based on as-reported figures from SEC (XBRL) filings.

What is Galectin Therapeutics Inc.'s Diluted EPS (TTM)?

Galectin Therapeutics Inc.'s Diluted EPS (TTM) is -0.28, based on as-reported figures from SEC (XBRL) filings.

What is Galectin Therapeutics Inc.'s Net Debt?

Galectin Therapeutics Inc.'s Net Debt is -$13.3M, based on as-reported figures from SEC (XBRL) filings.

Galectin Therapeutics Inc. (GALT) Financial Statements

Galectin Therapeutics Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S9NYW2

XNAS · usd

4.11▼ 0.03 (-0.72%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.14

Day's Range4.10 – 4.65

52-Week Range2.03 – 7.13

Volume391.1K

Avg Volume354.3K

Share Statistics

Shares Outstanding

Employees9

ExchangeXNAS

Listed2002-09-04

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Galectin Therapeutics Inc. (GALT)

What is Galectin Therapeutics Inc.'s Market Cap?: Galectin Therapeutics Inc.'s Market Cap is $414.5M, based on as-reported figures from SEC (XBRL) filings.
What is Galectin Therapeutics Inc.'s Enterprise Value?: Galectin Therapeutics Inc.'s Enterprise Value is $403.0M, based on as-reported figures from SEC (XBRL) filings.
What is Galectin Therapeutics Inc.'s Net Income (TTM)?: Galectin Therapeutics Inc.'s Net Income (TTM) is -$28.0M, based on as-reported figures from SEC (XBRL) filings.
What is Galectin Therapeutics Inc.'s Diluted EPS (TTM)?: Galectin Therapeutics Inc.'s Diluted EPS (TTM) is -0.28, based on as-reported figures from SEC (XBRL) filings.
What is Galectin Therapeutics Inc.'s Net Debt?: Galectin Therapeutics Inc.'s Net Debt is -$13.3M, based on as-reported figures from SEC (XBRL) filings.